Reliance Life Setting Up Biotech Lab Near Mumbai

Image
BUSINESS STANDARD
Last Updated : Feb 26 2013 | 12:54 AM IST

Reliance Life Sciences (RLS) is setting up a biotechnology laboratory complex at Thane, near Mumbai. The company has already awarded a contract to Kvaerner Power Gas (India), an engineering and design construction firm, to set up research and development facilities on the site.

The facility is expected to be in place by the end of 2002. The setting up of the labs is a small step towards launching commercial operations for the company's cell biology initiatives, which will cover embryonic stem cells, haematopoietic stem cells, skin cells and tissue engineering.

A Reliance spokesperson declined to comment on the development.

Also Read

The new complex will also support contract research jobs the company proposes to undertake. RLS has seven of the 64 lines of stem cells across the globe that were identified by the National Institute of Health in the US and which have received US Federal funding.

The Thane complex will come up in two phases. The first phase will involve setting up of labs for cell biology. This will involve an animal house for clinical trials, a greenhouse for plant biotechnology and other paraphernalia. Phase two will, however, involve the construction of other support systems critical for biotech laboratories.

Incorporated in January 2001, RLS has established a cell biology research centre in Mumbai. The centre is operated from Sir Hurkinsondas Nurrotamdas Hospital & Research Centre.

The Ambanis have invested approximately Rs 25 crore in setting up the centre at Sir H N Hospital. The Reliance group plans to invest close to $25 million over the next few years and is likely to scale up investments when the research results come up for commercial production.

The foray into biotechnology has a synergy with the group's existing business of polymers. The research centres are also developing new streams in polymers that are expected to be environment friendly.

RLS had earlier planned to set up three research facilities, one each for cell biology and plant biotech, with the third one being a composite facility.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 26 2002 | 12:00 AM IST

Next Story